Literature DB >> 31484726

Comprehensive analysis of long noncoding RNA (lncRNA)-chromatin interactions reveals lncRNA functions dependent on binding diverse regulatory elements.

Guanxiong Zhang1, Yujia Lan1, Aimin Xie1, Jian Shi1, Hongying Zhao1, Liwen Xu1, Shiwei Zhu1, Tao Luo1, Tingting Zhao2, Yun Xiao3, Xia Li4.   

Abstract

Over the past decade, thousands of long noncoding RNAs (lncRNAs) have been identified, many of which play crucial roles in normal physiology and human disease. LncRNAs can interact with chromatin and then recruit protein complexes to remodel chromatin states, thus regulating gene expression. However, how lncRNA-chromatin interactions contribute to their biological functions is largely unknown. Here, we collected and constructed an atlas of 188,647 lncRNA-chromatin interactions in human and mouse. All lncRNAs showed diverse epigenetic modification patterns at their binding sites, especially the marks of enhancer activity. Functional analysis of lncRNA target genes further revealed that lncRNAs could exert their functions by binding to both promoter and distal regulatory elements, especially the distal regulatory elements. Intriguingly, many important pathways were observed to be widely regulated by lncRNAs through distal binding. For example, NEAT1, a cancer lncRNA, controls 13.3% of genes in the PI3K-AKT signaling pathway by interacting with distal regulatory elements. In addition, "two-gene" signatures composed of a lncRNA and its distal target genes, such as HOTAIR-CRIM1, provided significant clinical benefits relative to the lncRNA alone. In summary, our findings underscored that lncRNA-distal interactions were essential for lncRNA functions, which would provide new clues to understand the molecular mechanisms of lncRNAs in complex disease.
© 2019 Zhang et al.

Entities:  

Keywords:  chromatin modification; epigenetics; gene regulation; long noncoding RNA (long ncRNA, lncRNA); survival; transcription enhancer

Mesh:

Substances:

Year:  2019        PMID: 31484726      PMCID: PMC6816106          DOI: 10.1074/jbc.RA119.008732

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  66 in total

1.  Identification of the long noncoding RNA NEAT1 as a novel inflammatory regulator acting through MAPK pathway in human lupus.

Authors:  Feifei Zhang; Lingling Wu; Jie Qian; Bo Qu; Shiwei Xia; Ting La; Yanfang Wu; Jianyang Ma; Jing Zeng; Qiang Guo; Yong Cui; Wanling Yang; Jiaqi Huang; Wei Zhu; Yihong Yao; Nan Shen; Yuanjia Tang
Journal:  J Autoimmun       Date:  2016-07-29       Impact factor: 7.094

Review 2.  Catching RNAs on chromatin using hybridization capture methods.

Authors:  Martin Machyna; Matthew D Simon
Journal:  Brief Funct Genomics       Date:  2018-03-01       Impact factor: 4.241

3.  Genome-scale deletion screening of human long non-coding RNAs using a paired-guide RNA CRISPR-Cas9 library.

Authors:  Shiyou Zhu; Wei Li; Jingze Liu; Chen-Hao Chen; Qi Liao; Ping Xu; Han Xu; Tengfei Xiao; Zhongzheng Cao; Jingyu Peng; Pengfei Yuan; Myles Brown; Xiaole Shirley Liu; Wensheng Wei
Journal:  Nat Biotechnol       Date:  2016-10-31       Impact factor: 54.908

4.  The matrix protein hnRNP U is required for chromosomal localization of Xist RNA.

Authors:  Yuko Hasegawa; Neil Brockdorff; Shinji Kawano; Kimiko Tsutui; Ken Tsutui; Shinichi Nakagawa
Journal:  Dev Cell       Date:  2010-09-14       Impact factor: 12.270

5.  The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome.

Authors:  Jesse M Engreitz; Amy Pandya-Jones; Patrick McDonel; Alexander Shishkin; Klara Sirokman; Christine Surka; Sabah Kadri; Jeffrey Xing; Alon Goren; Eric S Lander; Kathrin Plath; Mitchell Guttman
Journal:  Science       Date:  2013-07-04       Impact factor: 47.728

Review 6.  The emergence of lncRNAs in cancer biology.

Authors:  John R Prensner; Arul M Chinnaiyan
Journal:  Cancer Discov       Date:  2011-10       Impact factor: 39.397

Review 7.  Long non-coding RNAs: new players in cell differentiation and development.

Authors:  Alessandro Fatica; Irene Bozzoni
Journal:  Nat Rev Genet       Date:  2013-12-03       Impact factor: 53.242

8.  Prognostic role of long noncoding RNA NEAT1 in various carcinomas: a meta-analysis.

Authors:  Tao Chen; Hui Wang; Peng Yang; Zhen-Yu He
Journal:  Onco Targets Ther       Date:  2017-02-17       Impact factor: 4.147

9.  Pervasive transcription of the human genome produces thousands of previously unidentified long intergenic noncoding RNAs.

Authors:  Matthew J Hangauer; Ian W Vaughn; Michael T McManus
Journal:  PLoS Genet       Date:  2013-06-20       Impact factor: 5.917

10.  Association of the Long Non-coding RNA Steroid Receptor RNA Activator (SRA) with TrxG and PRC2 Complexes.

Authors:  Patompon Wongtrakoongate; Gregory Riddick; Suthat Fucharoen; Gary Felsenfeld
Journal:  PLoS Genet       Date:  2015-10-23       Impact factor: 5.917

View more
  13 in total

1.  LINC00200 contributes to the chemoresistance to oxaliplatin of gastric cancer cells via regulating E2F1/RAD51 axis.

Authors:  Mengxin Lin; Meifang Xu; Zongbin Xu; Zongqi Weng; Bingqiang Lin; Yanqin Lan; Qing Liu; Xiaoyan Lin; Jie Pan
Journal:  Hum Cell       Date:  2021-04-06       Impact factor: 4.174

2.  LncRNA HOXD-AS1 affects proliferation and apoptosis of cervical cancer cells by promoting FRRS1 expression via transcription factor ELF1.

Authors:  Huan Liu; Li Liu; Qiong Liu; Fengjiao He; Hong Zhu
Journal:  Cell Cycle       Date:  2022-01-05       Impact factor: 4.534

3.  Long noncoding RNA FER1L4 promotes the malignant processes of papillary thyroid cancer by targeting the miR-612/ Cadherin 4 axis.

Authors:  Luyao Wu; Yu Ding; Houchao Tong; Xi Zhuang; Jingsheng Cai; Yan Si; Hao Zhang; Xiaoting Wang; Meiping Shen
Journal:  Cancer Cell Int       Date:  2021-07-21       Impact factor: 5.722

4.  Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.

Authors:  Valentina Lulli; Mariachiara Buccarelli; Ramona Ilari; Giorgia Castellani; Chiara De Dominicis; Alessandra Di Giamberardino; Quintino Giorgio D Alessandris; Stefano Giannetti; Maurizio Martini; Vittorio Stumpo; Alessandra Boe; Gabriele De Luca; Mauro Biffoni; Giovanna Marziali; Roberto Pallini; Lucia Ricci-Vitiani
Journal:  Int J Mol Sci       Date:  2020-05-20       Impact factor: 5.923

5.  LncRNA NEAT1 Promotes High Glucose-Induced Mesangial Cell Hypertrophy by Targeting miR-222-3p/CDKN1B Axis.

Authors:  Lin Liao; Jie Chen; Chuanfu Zhang; Yue Guo; Weiwei Liu; Wenrui Liu; Lianxiang Duan; Ziyang Liu; Jing Hu; Jianrao Lu
Journal:  Front Mol Biosci       Date:  2021-01-27

6.  Imbalance of Molecular Module of TINCR-miR-761 Promotes the Metastatic Potential of Early Triple Negative Breast Cancer and Partially Offsets the Anti-Tumor Activity of Luteolin.

Authors:  Man-Li Zhang; Wei-Wei Liu; Wei-Dong Li
Journal:  Cancer Manag Res       Date:  2021-02-23       Impact factor: 3.989

Review 7.  Chromatin-Associated Membraneless Organelles in Regulation of Cellular Differentiation.

Authors:  Markus Grosch; Sebastian Ittermann; Dmitry Shaposhnikov; Micha Drukker
Journal:  Stem Cell Reports       Date:  2020-11-19       Impact factor: 7.765

8.  Analysis of lncRNAs and mRNA Expression in the ZBTB1 Knockout Monoclonal EL4 Cell Line and Combined Analysis With miRNAs and circRNAs.

Authors:  Junhong Wang; Xiaoxu Li; Yiyuan Lu; Quntao Huang; Yu Sun; Mingyang Cheng; Fengdi Li; Chunwei Shi; Yan Zeng; Chunfeng Wang; Xin Cao
Journal:  Front Cell Infect Microbiol       Date:  2021-12-09       Impact factor: 5.293

9.  The Novel Competing Endogenous Long Noncoding RNA SM2 Regulates Gonadotropin Secretion in the Hu Sheep Anterior Pituitary by Targeting the Oar-miR-16b/TGF-β/SMAD2 Signaling Pathway.

Authors:  Zhen Wan; Hua Yang; Peiyong Chen; Zhibo Wang; Yu Cai; Xiaolei Yao; Feng Wang; Yanli Zhang
Journal:  Cells       Date:  2022-03-14       Impact factor: 6.600

10.  LncRNA-HOTAIR promotes endothelial cell pyroptosis by regulating the miR-22/NLRP3 axis in hyperuricaemia.

Authors:  Kun Chi; Xiaodong Geng; Chao Liu; Yang Zhang; Jie Cui; GuangYan Cai; Xiangmei Chen; Fangfang Wang; Quan Hong
Journal:  J Cell Mol Med       Date:  2021-07-22       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.